ALAM SHARIFI: Open Payments
NPI 1669873774 · COVINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 29 payments from 9 companies in 2025. Trend: 2023 $319 · 2024 $385 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $177 |
| Alkermes, Inc. | 8 | $146 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: COBENFY, ARISTADA, HETLIOZ, INGREZZA, INVEGA SUSTENNA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
